乳房のフィロデス腫瘍:包括的なレビュー
Eun-Shin Lee1, Hyunyou Kim1, Harim Oh2
1Department of Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Annals of surgical treatment and research
|February 13, 2026
まとめ
フィロデスの腫瘍は,希少な乳腺新生体です. このレビューは,それらの特徴と管理に関する証拠を統合し,個別化された治療の必要性と,ターゲティングセラピーに関するさらなる研究を強調しています.
科学分野:
- 腫瘍学 腫瘍学
- 病理学 パトロジー
- 遺伝学 遺伝学とは
背景:
- Phyllodes腫瘍は,異なる悪性腫瘍の可能性を持つ希少な二相性繊維皮質性乳腺腫瘍である.
- 悪性フィロド腫瘍は,再発および転移の重大なリスクがあります.
研究 の 目的:
- フィロド型腫瘍の臨床的,組織病理学的,分子的特徴に関する現在の証拠をレビューする.
- 治療戦略,予後要因,管理上の課題に関する情報を統合する.
- 標的型療法を含む将来の研究方向を特定する.
主な方法:
- 臨床プレゼンテーション,イメージング,および組織病理学の包括的な文献レビュー.
- 手術による治療,補助療法,および結果の評価.
- 最近のゲノムおよび分子研究の評価.
主要な成果:
- 臨床的異質性およびコア生検の限界のために,外科的組織病理学による決定的な分類は極めて重要です.
- 手術の限界,補助放射線療法,およびフォローアッププロトコルに関する課題は依然として存在しています.
- 分子プロファイリングは,攻撃的または転移した症例における標的治療の有望性を示しています.
結論:
- 適合した管理戦略は,フィロドスの腫瘍に不可欠です.
- 現在の管理のギャップを埋めるために,さらなる質の高い研究が必要である.
- 分子理解の進歩は,新しい標的治療アプローチにつながる可能性があります.
さらに関連する動画
関連する概念動画
Review and Preview
8.4K
In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
Percentiles are a type of fractile that partition data into...
Percentiles are a type of fractile that partition data into...
8.4K
Review and Preview
11.6K
Data are individual items of information obtained from a population or sample. Data may be classified as qualitative (categorical), quantitative continuous, or quantitative discrete. Because it is not practical to measure the entire population in a study, researchers use samples to represent the population. A random sample is a representative group from the population chosen by using a method that gives each individual in the population an equal chance of being included in the sample. Random...
11.6K
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
The Tumor Microenvironment
7.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
Cancer Stem Cells and Tumor Maintenance
6.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K


